Case Study: Lotus Clinical Research Achieves Excellence in Clinical Research and Quality Management with ETQ Reliance

Since its inception in 2001, Lotus has strategically leveraged its expertise and regulatory knowledge to guide biopharmaceutical partners through successful clinical trials, from phase 1 to phase 4. Owned by Emerge Holdco, LLC, which also owns Evolution Research Group, LLC (ERG), Lotus stands out for its ability to mitigate risks at both the site and study levels. This is achieved through a blend of therapeutic expertise and an exceptional talent pool across medical, operational, and support functions.

Download this case study to learn:

• How Lotus automated its infrastructure to enhance compliance with FDA regulations.
• The impact of these changes on quality and efficiency.
• How enterprise-wide visibility drives standardization across clinical sites.